https://www.fiercepharma.com/marketing/gsks-arexvy-lead-new-rsv-vaccines-sales-race-moderna-close-second-report
0
0
GSK's Arexvy to lead new RSV vaccines sales race with Moderna a close second: report - FiercePharma
7/24/23 at 2:44pm
Organization
FiercePharma
Author
FiercePharma
17 words
0
Comments
You are the first to view
Create an account or login to join the discussion